DOWNLOAD

Tech Transfer Optimisation: Download the Case Study

How to optimise technology transfer and scale-up through risk-based methodologies

Discover how risk-based methodologies help CDMOs cut tech transfer validation timelines by up to 40% and reduce costs by more than 50%.

Download the case study today and access proven strategies for faster, safer technology transfer.

Brought to you by Suanfarma, this case study highlights how risk-based methodologies can transform technology transfer and scale-up in CDMOs. By applying structured approaches, companies can save months of time and millions in cost, while ensuring scalability, compliance, and stronger partnerships.

Why read this case study?

Technology transfer and scale-up are critical moments in drug development. This case study demonstrates how a risk-based approach delivered measurable improvements in CDMO projects — from small molecule synthesis to fermentation-based processes.

You’ll learn how to:

  • Reduce validation time by up to 40–50% with integrated planning.
  • Achieve 31% faster delivery and 54% lower costs in real projects.
  • Identify and mitigate risks early to avoid costly reworkImprove scalability and compliance for global regulatory submissions.
  • Strengthen CDMO partnerships with robust frameworks like TT&GO®.
  • Review real-world examples comparing traditional vs. risk-based approaches, including lessons learned from failed strategies.

Suanfarma is a global pharmaceutical group and CDMO with over 25 years of experience in the development, manufacture, and commercialisation of active pharmaceutical ingredients (APIs). With a strong international presence and commitment to innovation, Suanfarma supports pharma and biotech companies worldwide through advanced capabilities, regulatory expertise, and sustainable manufacturing solutions.

Download the Tech Transfer Case Studies by Suanfarma

Testimonials
"If you are looking for a reliable family feel partner in your CMO services than look no further than Suanfarma. They have been a long-trusted partner, working side by side with us through the complete life cycle of our product.

They have always taken the time to understand who we are as individuals and as company, what our current challenges and needs are, and work closely as true partners to deliver toward our success with the most important common goal of always ensuring continuous supply of the highest quality."
Randy Brenner
Chief Development and Regulatory Officer
Paratek Pharmaceuticals
"Isomerase has worked with Suanfarma on multiple projects where we are looking to help our clients move their projects to the next stage in development.

The heritage and experience the Suanfarma team have, specifically in natural products, makes them an obvious candidate CDMO that we are happy to recommend to clients.."
Steven Moss
Co-founder and CTO
ISOMERASE
Who do you rate?
Recommend a Supplier

Help us find the most innovative and trusted suppliers in Pharma and Biotech.